Investors Inquire About Securities Class Action Against Ensign Group
Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG). The probe centers on allegations that the company may have issued misleading business information to the public.
New York – October 2, 2026 – Rosen Law Firm, a global investor rights law firm, is continuing its investigation into potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG). The investigation stems from allegations that Ensign may have issued materially misleading business information to the investing public.
The inquiry follows a report published on June 8, 2026, by Investing.com, which cited a short seller's report from Hunterbrook. This report alleged that Ensign's business model relies on inadequate patient care and the manipulation of quality metrics. Hunterbrook's five-month investigation purportedly found that the company's profits depend on understaffing facilities while directing taxpayer funds to executives and affiliates, with the report claiming patients suffered and died as a result.
Following the news of the short seller's report, Ensign Group's stock fell by 8.15% on June 8, 2026. Rosen Law Firm is preparing a class action lawsuit seeking to recover investor losses. Individuals who purchased Ensign securities may be entitled to compensation without incurring out-of-pocket expenses, under a contingency fee arrangement.
Rosen Law Firm encourages investors to select counsel with a strong track record in securities litigation. The firm specializes in class action lawsuits and shareholder derivative litigation, representing investors worldwide. Further details on how to participate in the potential class action are available on the firm's website.